Team

Leadership, Insight, Innovation.

Matthew Boyer

Matthew Boyer

Chief Financial Officer

Matt has over 20 years of finance, accounting and operational experience in the asset management industry.

Jason Burke

Jason Burke

Advisor

Jason is an Advisor to Pappas Capital where he is involved in the firm’s assessment of disruptive technologies.

Antonio Chow

Antonio Chow

Asia Regional Advisor

Antonio serves as the firm's Regional Advisor in Asia.

Glenda Crumpler

Glenda Crumpler

Executive Assistant

Glenda's broad strong organization skills help keep Pappas Capital running smoothly.

Drew Cutshaw, MD

Drew Cutshaw, MD

Senior Associate

Patrick Daly

Patrick Daly

Executive-in-Residence

Patrick is a seasoned global executive with a proven track record of entrepreneurship, building winning cultures and growing companies small and large.

Lisa Dreyer

Lisa Dreyer

Senior Associate, Operations

Lisa brings a depth of experience in finance and operations from her years in the Alternative Investments industry.

Brian Gibbs, PhD

Brian Gibbs, PhD

Investment Analyst and Deal Flow Manager

Miranda Gottlieb

Miranda Gottlieb

Venture Partner

Miranda has extensive experience working with early-stage companies in the US and Asia.

Mike Grey

Mike Grey

Venture Partner

Mike’s extensive company management background enables him to bring an operational viewpoint to new deal opportunities and existing portfolio companies.

Franz Humer, PhD

Franz Humer, PhD

Venture Partner and Senior Advisor

Dr. Humer brings a wealth of leadership experience from the pharmaceutical and life science industries.

Russel Kaufman, MD

Russel Kaufman, MD

Executive-in-Residence and Scientific Advisory Board

With long-standing interests in both basic and applied cancer research, Russel has held leadership positions in national academic organizations in internal medicine.

Elizabeth Kelly

Elizabeth Kelly

Principal

Elizabeth has more than a decade of experience working with early-stage life science and technology companies.

Bert Kinsey, PhD, PharmD

Bert Kinsey, PhD, PharmD

Principal

Bert is a seasoned executive with significant experience in translational biomedical research and biotechnology equity research.

Phil Kohn

Phil Kohn

Executive-in-Residence

Phil focuses on consulting on digital strategies for new media and emerging technology companies.

Stanley Lau

Stanley Lau

Special Advisor

Stanley has over 40 years of business and healthcare experience in China and internationally.

Karen LeVert

Karen LeVert

Venture Partner

Karen has a long history of developing early stage technologies and launching them into the marketplace.

Ernie Mario, PhD

Ernie Mario, PhD

Venture Partner

Ernie has 45 years of experience in the research-based pharmaceutical industry.

Tom Mathers

Tom Mathers

Partner

Tom has more than 28 years of executive management experience in the life sciences and medical device industry.

Barry Myers, MD, PhD

Barry Myers, MD, PhD

Venture Partner

Barry has been a member of the Duke University faculty for 29 years. His broad base of expertise enables him to provide a distinctive view on portfolio companies.

Art Pappas

Art Pappas

Managing Partner

Art has over 40 years of operating experience as a pharmaceutical and biotechnology industry executive and venture capital investor in life science companies.

David Savello, PhD

David Savello, PhD

Venture Advisor and Scientific Advisory Board

Dave has an extensive career, holding senior level positions at companies such as Glaxo Inc., Glaxo Wellcome Inc., Warner Lambert Corporation and Boehringer Ingelheim Ltd.

Victor Shi, PhD

Victor Shi, PhD

Special Advisor

Victor has deep operating and investing experience with early-stage companies in Asia.

Thyagi Thyagarajan

Thyagi Thyagarajan

Special Advisor

Thyagi has an in-depth knowledge of Asia and Asian markets, and a unique east-west perspective from working in both developed and emerging markets.

Bob White

Bob White

Senior Advisor

Bob has an extensive background in the medical device industry, including the successful sale of TYRX to Medtronic in 2013.

Tina Wong-Russell

Tina Wong-Russell

Advisor

Tina brings a global perspective to Pappas Capital from years of working in Europe, Latin and North America, and especially Asia.

Ford Worthy

Ford Worthy

Partner and Senior Advisor

Ford is a lawyer with an extensive background in finance and accounting, and currently serves as a Senior Advisor to Pappas Capital.

Peter Young

Peter Young

Venture Partner

Peter has 40 years of experience in the biotech and pharmaceutical industries, and leads the firm's efforts in translational medicine.

Catherine Yue, PhD

Catherine Yue, PhD

Associate

Catherine has a decade of experience working with research institutes and early-stage startups in the deeptech area